| Thursday, July 02, 2009 |
| 10:00:00 AM |
Rahul Nandurdikar, PhD |
Bldg 549 Auditorium |
| |
Developing Multivalent Nitric Oxide Donors
|
Details
Series
|
| Tuesday, July 07, 2009 |
| 8:00:00 AM |
Klaus Rajewsky, MD |
Bldg 549 Conf. Rm B |
| |
A Mouse Model for Post-Transplant Lymphoproliferative Disorder (PTLD)
|
Details
Series
|
|
| 12:00:00 PM |
Dr. Peter Hobart |
Bldg 549 Auditorium |
| |
Controlling Expression of Exogenously Delivered Genes to Circumvent the Immune Response
|
Details
Series
|
| Wednesday, July 08, 2009 |
| 2:00:00 PM |
Matthias Gromeier |
Bldg 549 Auditorium |
| |
Targeting Translation Control in Cancer
|
Details
|
| Tuesday, July 14, 2009 |
| 8:00:00 AM |
David P. Carbone,MD, PhD |
Bldg 549 Conf. Rm B |
| |
Molecular Signatures of Lung Cancer
|
Details
Series
|
|
| 12:00:00 PM |
Dr. Christopher Cote |
Bldg 549 Auditorium |
| |
Bacillus anthracis: Early Interactions with the Host
|
Details
Series
|
| Tuesday, July 21, 2009 |
| 12:00:00 PM |
Dr. Melinda Hollingshead |
Bldg 549 Auditorium |
| |
Animal Models in Drug Development
|
Details
Series
|
| Tuesday, July 28, 2009 |
| 12:00:00 PM |
Dr. Dimiter Dimitrov |
Bldg 549 Auditorium |
| |
Therapeutic Antibodies - The Dream of Magic Bullets Achieved?
|
Details
Series
|
|
| 2:00:00 PM |
Angela Gronenborn, PhD |
Bldg 549 Auditorium |
| |
Host Txn Factors and Antiviral Protein Structures
|
Details
Series
|
|
